Individual decision · SEC · 26 Feb 2019
The Staff of the Division of Trading and Markets will not recommend enforcement action to the Commission under Rule 1004 of Regulation SCI if specified SCI entities conduct annual business continuity and disaster recovery plan testing in the same calendar month as the prior year, provided the testing occurs more than 365 days after the previous test date. This relief applies to SIFMA members, similarly situated broker-dealers, and the SCI entities listed in Exhibit 1, including national securities exchanges, registered clearing agencies, FINRA, and the MSRB. The Staff's position is based on the need to coordinate industry-wide testing dates to align with other major industry programs and avoid operational conflicts, such as option expiry weekends, while ensuring practical utility without imposing undue cost.
~o exc
~~~v ~~ UNITED STATES
3 SECURITIES AND EXCHANGE COMMISSION s~ ~o` WASHINGTON, D.C. 20549 "~MxxxN DIVISION OF TRADING AND MARKETS February 26, 2019 Ellen Greene Managing Director SIFMA 120 Broadway, 35th Floor New York, NY 10271 Re: Request Re arding Rule 1004 of Regulation SCI Dear Ms. Greene:
In your letter dated February 25, 2019, you request assurance, acting on behalf of SIFMA members and other similarly situated broker-dealers, as well as the SCI entities' listed on Exhibit 1 to your letter, that the staff of the Division of Trading and Markets ("Staff') would not recommend enforcement action to the Commission under Rule 1004 of Regulation Systems Compliance and Integrity ("Regulation SCI)2 if SCI entities conduct the annual testing of business continuity and disaster recovery plans ("BC/DR plans") required by Rule 1004 in the same calendar month as the prior year, but more than 365 days after the testing date of the prior year. Rule 1004 requires, among other things, that an SCI entity perform functional and performance testing of the operation of its BC/DR plans3 with members or participants "not less than once every 12 months" and that the testing of such plans be coordinated on an industry- or sector-wide basis with other SCI entities. In your letter, you describe the factors that SIFMA and SCI entities consider "to determine the most effective date to conduct the annual testing." In particular, you note that coordinated selection of the test date each year takes into account a range of considerations, such as option expiry weekends, internal firm or exchange-specific operations, technology processes Under Rule 1000 of Regulation SCI, the term SCI entity includes self-regulatory organizations ("SROs") (including stock and options exchanges, registered clearing agencies, FINRA and the MSRB), alternative trading systems ("ATSs") that trade NMS and non-NMS stocks exceeding specified volume thresholds, disseminators of consolidated market data ("plan processors"), and certain exempt clearing agencies. 17 CFR 242.1004. Rule 1001(a)(2)(v) of Regulation SCI requires members to have BC/DR plans that include maintaining backup and recovery capabilities sufficiently resilient and geographically diverse and that are reasonably designed to achieve next business day resumption of trading and two-hour resumption of critical SCI systems following awide-scale disruption. See 17 CFR 242.1001(a)(2)(v).
Ms. Ellen Greene
February 26, 2019
(e.g., major planned systems changes), holidays, and other major industry testing programs.4 Because of these factors, SIFMA seeks flexibility to conduct the testing required by Rule 1004 in the same calendar month as a prior year's test, but more than 365 days after the most recent test, if necessary to establish the most effective testing date. For example, the 2018 coordinated BC/DR plan testing occurred on October 10th, and SIFMA, after consideration of the factors noted above, tentatively proposes that the next coordinated testing be conducted on October 26n, 2019, and that testing for the two following years be conducted on October 24th, 2020 and October 23d, 2021. As discussed in the SCI Adopting Release and noted in your letter, the key with respect to the frequency of coordinated BC/DR testing is that it should "occur regularly enou~h to offer practical utility in the event of a wide-scale disruption without imposing undue cost." Further, the Commission recognized that coordinating industry-wide testing among SCI entities and their members or participants may "present logistical challenges."6 The Staff recognizes that the selection of a single date for industry-wide coordinated testing is not a simple matter, and necessarily requires coordination with many entities and consideration of many factors as you noted in your letter. The Staff is also cognizant that certain periods may not be optimal for this testing because ofmarket-related events (e.g., option expiry weekends), holidays, or other operational reasons. Therefore, based on the facts and representations set forth in your letter, the Staff would not recommend enforcement action to the Commission if the testing required by Rule 1004 occurred in the same calendar month as a prior year, but more than 365 days after the most recent test; however, given the importance of the BC/DR testing requirement in ensuring that SCI entities' BC/DR plans operate as intended in the event of a wide scale disruption, the staff believes that it is appropriate that SCI entities give due consideration to all of these factors and choose a testing date that will allow for the most effective testing. This Staff position is based strictly on the facts and representations set forth in your letter and any different facts or representations may require a different response. This response, furthermore, expresses the Staff s position with respect to enforcement action only and does not purport to express any legal conclusions. The Staff expresses no view with respect to any other In particular, your letter references the SIFMA Business Continuity Planning tests, the Futures Industry Association ("FIA") annual test, as well as the Investment Industry Regulatory Organization of Canada ("IIROC") test. According to your letter, "[a]ligning the dates of these tests creates substantial efficiencies for the test entities and participating firms and thus reduces operational and technology risks." See SCI Adopting
Release, 79 FR at 72354. See id.
Ms. Ellen Greene
February 26, 2019 questions that the proposed activities may raise, including the applicability of any other federal or state laws, or self-regulatory organization rules. This position is subject to modification or revocation at any time. Sincerely, V~ ~~ David S. Shillman Associate Director Division of Trading and Markets
Securities and Exchange Commission
SIFMA Request for No Action Relief from Rule 1001 of Regulation SCI February 25, 2019 at least once every 12 months. In adopting Regulation SCI, the Commission stated that the key for operational testing off BC/DR plans "is for testing to occur regularly enough to offer practical utility in the event of a wide-scale disruption without imposing undue cost, and that a minimum frequency of one year achieves this balance."4 Regulation SCI took effect on February 3, 2015 with the first required operational testing of BC/DR plans having to occur by a deadline of November 3, 2016.5 For the 2017 testing of BC/DR plans, the requirement under Rule 1004(c) for industry- or sector-wide coordination was in effect.6 Since October 2016, the SCI entities have conducted the required operational testing of BC/DR plans in coordination with the annual SIFMA Business Continuity Planning tests, which currently are held in October of every calendar year. The 2018 test was held on October 13~'. SIFMA and SCI entities coordinate to determine the most effective date to conduct the annual testing of BC/DR plans under Regulation SCI after considering several factors. SCI entities and SIFMA member firms seek to avoid weekends where industry testing would be difficult, including options expiry weekends, internal firm operations and technology processes associated with calendar cycles, and holidays. In addition, there are major exchange system conversions planned in October 2019 that require their own weekend testing programs and limit the number of available weekends in October 2019 to conduct the Regulation SCI tests. If the test were moved to September for 2019, then SCI entities would face the same timing issue for 2020 in order to move the test back to October. SIFMA Request to Allow Testing to Occur During a Single Calendar Month Beginning with the 2019 BC/DR test, SIFMA requests that the Division Staff provide assurances that it will not recommend to the Commission enforcement action based on the annual testing required under Rule 1004 occurring in the same calendar month as the prior year's test but more than 365 days after the prior year's test. SIFMA proposes the 2019 testing of BC/DR plans to be held on Saturday October 26th, which would be more than 365 days after the 2018 test date of October 13~`. SIFMA tentatively proposes that the testing dates for the two following years would be Saturday October 24, 2020 and Saturday, October 23, 2021. Permitting the annual BC/DR testing to be held in the same calendar month as the prior year's test, as opposed to strictly within 365 days of the previous testing date, allows for alignment of the Regulation SCI test (and the SIFMA industry connectivity test) with other major industry testing programs such as the Futures Industry Association ("FIA") annual test, as well as the Investment Industry Regulatory Organization of Canada ("IIROC") test, which occurs every other year. SIFMA coordinates with the FIA and IIROC to identify
potential test weekends and Id. at 72354. Id. at 72367. Id.
Securities and Exchange Commission
SIFMA Request for No Action Relief from Rule 1001 of Regulation SCI February 25, 2019 have collectively agreed to these proposed testing dates. Aligning the dates of these tests creates substantial efficiencies for the test entities and participating firms and thus reduces operational and technology risks. Conclusion For the reasons stated above, SIFMA requests the Division provide assurances that it will not recommend enforcement actions to the Commission for entities failing to comply with Rule 1004 of Regulation SCI if the required annual testing of BC/DR plans occur during October of every calendar year, even if the testing date in one year is more than 365 days after the testing date in the prior year. SIFMA greatly appreciates the Commission's consideration of the issues raised above and would be pleased to discuss these comments in greater detail with the Commission and the Staff. If you have any questions or need any additional information, please contact me at 212-313-1287 or e rg eene(a,SIFMA.org. Sincerely, ~1Za~„~ ~ ~.~,.~ Ellen Greene Managing Director SIFMA
Securities and Exchange Commission
SIFMA Request for No Action Relief from Rule 1001 of Regulation SCI February 25, 2019 Exhibit 1:
The following SCI entities have consented to SIFMA's submission of this letter on their behalf:
BOX Exchange LLC;
The national securities exchanges operated by Cboe Global Markets: Cboe BYX Exchange, Inc., Cboe BZX Exchange, Inc., Cboe C2 Exchange, Inc., Cboe EDGA Exchange, Inc., Cboe EDGX Exchange, Inc., and Cboe Exchange, Inc.; The registered clearing agencies and exempt clearing agencies operated by the Depository Trust &Clearing Corporation: The Depository Trust Company, The Fixed Income Clearing Corporation, The National Securities Clearing Corporation, and Omgeo; The Financial Industry Regulatory Authority; Investors Exchange LLC; The national securities exchanges operated by Miami International Holdings, Inc.:
MIAX International Securities Exchange LLC and MIAX PEARL, LLC; The Municipal Securities Rulemaking Board; The national securities exchanges and alternative trading system operated by Intercontinental Exchange, Inc.: the Chicago Stock Exchange, Inc., New York Stock Exchange LLC, NYSE American LLC, NYSE Arca, Inc., NYSE National, Inc., and Global OTC; The national securities exchanges operated by Nasdaq, Inc.: The Nasdaq Stock Market LLC, Nasdaq BX, Inc., Nasdaq GEMX, LLC, Nasdaq ISE, LLC, Nasdaq MRX, LLC, and Nasdaq PHLX LLC; The Options Clearing Corporation; and OTC Link ATS
Note from RegAlert. AI assistants can read this document in full, and search 70,000+ more, through the RegAlert MCP connector (https://mcp.regalert.today/mcp). Free with an account. How to connect ChatGPT, Claude or Cursor.
The documents this one cites, and the documents that cite it.
“under the Securities Exchange Act of 1934 ("Exchange Act")3 if SCI entities conduct the annual testing”
More like this from SEC
SEC published 5 documents in the last 30 days. We email you each new one the day it's published.
Source: Securities and Exchange Commission — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works
In RegAlert: added · updated